Detalles de la búsqueda
1.
Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer.
Int J Mol Sci
; 19(11)2018 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30405053
2.
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852738
3.
A Case of Warm Autoimmune Hemolytic Anemia Secondary to Epstein-Barr Virus Infection.
Cureus
; 14(6): e26371, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35911306
4.
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
Clin Lung Cancer
; 22(3): e379-e389, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653295
5.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
JAMA Oncol
; 7(12): 1856-1861, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734989
6.
Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC.
JTO Clin Res Rep
; 1(4): 100074, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589955
7.
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
J Immunother Cancer
; 7(1): 169, 2019 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31277704
Resultados
1 -
7
de 7
1
Próxima >
>>